References
- Youssef M, Bassim M, Shabb N, et al. Aspergillus mastoiditis in an immunocompetent patient: a case report and review of the literature. Scand J Infect Dis. 2014;46:325–330.
- Chen L, Liu Y, Wang W, et al. Adrenal and hepatic aspergillosis in an immunocompetent patient. Infect Dis (Lond). 2015;47:428–432.
- Verweij PE, Snelders E, Kema GH, et al. Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use? Lancet Infect Dis. 2009;9:789–795.
- Snelders E, van der Lee HAL, Kuijpers J, et al. Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. PLoS Med. 2008;5:e219.
- Groll AH, Castagnola E, Cesaro S, et al. Fourth European conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation. Lancet Oncol. 2014;15:e327–e340.
- van der Linden JWM, Camps SMT, Kampinga GA, et al. Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles. Clin Infect Dis. 2013;57:513–520.
- Alanio A, Sitterle E, Liance M, et al. Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies. J Antimicrob Chemother. 2011;66:371–374.
- Van der Linden JWM, Snelders E, Arends JP, et al. Rapid diagnosis of azole-resistant aspergillosis by direct PCR using tissue specimens. J Clin Microbiol. 2010;48:1478–1480.
- Snelders E, Camps SMT, Karawajczyk A, et al. Triazole fungicides can induce cross-resistance to medical triazoles in Aspergillus fumigatus. PLoS One. 2012;7:e31801.
- Thorstensen CW, Lode O. Laboratory degradation studies of bentazone, dichlorprop, MCPA, and propiconazole in Norwegian soils. J Environ Qual. 2001;30:947–953.